Aug 9, 2025, 21:47

CPRIT Recruitment or Retention of Clinical Trialists Award

The Cancer Prevention and Research Institute of Texas (CPRIT) will fund Texas-based institutions to recruit or retain experienced oncology clinical trialists to expand access to phase 2/3 therapeutic cancer trials in rural and underserved communities across Texas.

Eligibility Criteria:

Applicant must be a Texas-based public or not-for-profit institution, health system, or community hospital serving rural/underserved populations; private companies are ineligible.
One application per institution.
PI requirements: MD/MD-PhD/DO (or equivalent); Texas license (active for retention nominees) and Texas residency by contract start and for award duration; oncology subspecialty training and credentialed for oncology patient care; nominated by an institutional leader.
Focus must increase access to phase 2–3 therapeutic trials in community settings; surgery-only, radiation-only, imaging-only, behavioral/prevention-only trialists are not appropriate.
Institution must guarantee 40–50% protected time for the PI and provide an institutional financial commitment ≥ 50% of the CPRIT award over the grant term.

Funding Details:

Amount & term: Up to USD 2,000,000 (Assistant Professor), USD 2,500,000 (Associate Professor), or USD 3,000,000 (Professor) over 5 years.
Allowable uses: PI salary support within USD 225,000/FTE CPRIT cap for protected time; essential trial staff (e.g., research nurses, regulatory managers); trial start-up costs; no construction/renovation.
Indirect costs: Up to 5% of total award (≈ 5.263% of direct costs).
Institutional match (contractual): Before funds are disbursed, recipient must demonstrate available matching funds equal to one-half of CPRIT funding at execution and annually thereafter.

Deadline:

Application receipt dates (FY26): January 20, 2026; March 20, 2026; May 20, 2026.

Where to Go for Further Information:

How to apply: Submit via the CPRIT Application Receipt System (CARS); see the RFA/IFA for step-by-step guidance. Helpdesk supports CARS-related questions.
Helpdesk: [email protected] (Mon–Fri, 8 AM–6 PM CT).
Program questions: [email protected]

cancer CARS portal Children's Oncology Group clinical trials CPRIT investigator funding NCI Community Oncology Research Program OncoDaily Oncology recruitment award RRCTA rural oncology Texas TREC

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth

New FDA PreCheck Program to Boost U.S. Drug Manufacturing

Vinay Prasad Rejoins FDA Days After Exit